Author:
Pham Minh N.,Ko Oliver S.,Huang Reiping,Vo Amanda X.,Tsai Kyle P.,Lai Jeremy D.,Hudnall Matthew T.,Halpern Joshua A.,Meeks Joshua J.,Benson Jonas,Soares Ricardo,Kim Ronald,Bilimoria Karl Y.,Stulberg Jonah J.,Auffenberg Gregory B.
Funder
National Institutes of Health
Northwestern University
Reference24 articles.
1. American Urologic Association & Society of Urologic Oncology. Diagnosis and treatment of non-muscle invasive bladder cancer. 2020.https://www.auanet.org/documents/education/clinical-guidance/non-muscle-invasive-bladder-cancer.pdf
2. National Comprehensive Cancer Society. NCCN guidelines for bladder cancer. 2020. https://jnccn.org/view/journals/jnccn/18/3/article-p329.xml
3. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC Studies;Brausi;European Urology,2002
4. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series;Gendy;BJU Int,2016
5. Detrusor muscle in TUR-derived bladder tumor specimens: can we actually improve the surgical quality?;Capogrosso;J Endourol,2016